• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Celgene Corporation

Celgene Corporation

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Celgene Receives Positive CHMP Opinion for ABRAXANE® for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

    Celgene Receives Positive CHMP Opinion for ABRAXANE® for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

  2. Research and Markets: Lung Cancer Clinical Trial Overview 2014

    Research and Markets: Lung Cancer Clinical Trial Overview 2014

  3. Oral OTEZLA® (apremilast) Approved by the European Commission for the Treatment of both Patients with Psoriasis and Psoriatic Arthritis

    Oral OTEZLA® (apremilast) Approved by the European Commission for the Treatment of both Patients with Psoriasis and Psoriatic Arthritis

  4. Father of PEGylation to Receive Dr. Sol J. Barer Award at Gateway Gala, BioNJ’s 22st Annual Dinner Meeting, Networking Event and Innovation Celebration

    Father of PEGylation to Receive Dr. Sol J. Barer Award at Gateway Gala, BioNJ’s 22st Annual Dinner Meeting, Networking Event and Innovation Celebration

  5. UPDATE: Major U.S. benchmarks challenge last-ditch support

    UPDATE: Major U.S. benchmarks challenge last-ditch support

  6. UPDATE: GameStop shares rally on strong holiday sales

    UPDATE: GameStop shares rally on strong holiday sales

  7. UPDATE: GameStop shares rally on strong holiday sales

    UPDATE: GameStop shares rally on strong holiday sales

  8. UPDATE: Three investments to own and three to

    UPDATE: Three investments to own and three to

  9. UPDATE: Apple, Monster Beverage get upgrades; Freeport-McMoRan slides

    UPDATE: Apple, Monster Beverage get upgrades; Freeport-McMoRan slides

  10. Celgene's stock rises, but off highs after profit outlook

    Celgene's stock rises, but off highs after profit outlook

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.